Generic Dexone depresses formation, release, and activity of endogenous mediators of inflammation, including prostaglandins, kinins, histamine, liposomal enzymes, and complement expression. Also modifies the body's immune response.
Siltuximab May Be Effective In Certain Patients With Advanced Multiple Myeloma ... - The Myeloma Beacon
Siltuximab May Be Effective In Certain Patients With Advanced Multiple Myeloma .
Tragedy strikes - PakistanToday.com.pk
PakistanToday.
Glucocorticoid-Induced Osteoporosis - Journal of Clinical Endocrinology and Metabolism
Glucocorticoid-Induced OsteoporosisJournal of Clinical Endocrinology and MetabolismThey include medicines such as prednisone, cortisone, hydrocortisone, and dexamethasone.
Marizomib May Be Effective In Relapsed / Refractory Multiple Myeloma (ASH 2011) - The Myeloma Beacon
Marizomib May Be Effective In Relapsed / Refractory Multiple Myeloma (ASH 2011)The Myeloma BeaconCombined data from two recent Phase 1 clinical trials suggest that twice-weekly marizomib, with or without low-dose dexamethasone, may be effective for patients with relapsed or refractory multiple myeloma.
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012 - MarketWatch (press release)
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012MarketWatch (press release)Phase 2 trial in combination with dexamethasone in patients with MM refractory to lenalidomide, bortezomib and dexamethasone therapy 2.